Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial

British Medical Journal

Volumn 280, Issue 6228, 1980, Pages 1340-1344

  Reeve, Jonathan ^a   Klenerman, Leslie ^a   Meunier, Pierre J ^b   Edouard, Claude ^b   Courpron, Philippe ^c   Parsons, John A ^d   Bernat, Michel ^e   Renier, Jean C ^e   Bijvoet, Olav L M ^f   Vismans, F Jon F E ^g   Neer, Robert M ^h   Slovik, David ^h   Potts, John T ^h  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b UNIVERSITÉ DE LYON   (France)

^c Francheville   (France)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e UNIVERSITÉ D'ANGERS   (France)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g St Elizabeth Hospital   (Netherlands)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM 47; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RADIOISOTOPE;

BONE; DRUG THERAPY; ENDOCRINE SYSTEM; INVOLUTION; MENOPAUSE; OSTEOPOROSIS; SUBCUTANEOUS DRUG ADMINISTRATION; THERAPY; TRABECULAR BONE;

AGED; BONE AND BONES; BONE DEVELOPMENT; BONE RESORPTION; CALCIUM; CLINICAL TRIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE;

EID: 0018839378     PISSN: 00071447     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.280.6228.1340     Document Type: Article

References (23)

1. Marshall JH, Liniecki J, Lloyd EL, et al. Alkaline earth metabolism in adult man. Health Phys 1973;24:125–221.
2. Reeve J, Hesp R, Wootton R. A new tracer method for the estimation of rates of bone formation and breakdown in man. Calcif Tissue Res 1977;22, suppl:311–3.
3. Cohn SH, Ellis KJ, Wallach S, Zanzi I, Atkins HL, Aloia JF. Absolute and relative deficit in total skeletal calcium and radial bone mineral in osteoporosis. J Nucl Med Allied Sci 1974;15:428–35.
4. Reeve J, Hesp R, Williams D, et al. The anabolic effect of low doses of human parathyroid hormone fragment on the skeleton in postmenopausal osteoporosis. Lancet 1976;i:1035–8.
5. Parsons JA, Bernat M, Bijvoet OLM, et al. Low doses of a synthetic fragment of human parathyroid hormone (hPTH 1–34) as a stimulus to bone formation. In: Barzel US, ed. Osteoporosis II. New York: Grune and Stratton, 1979:151–9.
6. Reeve J, Tregear GW, Parsons JA. Preliminary trial of low doses of human parathyroid hormone 1–34 peptide in treatment of osteoporosis. Calcif Tissue Res 1976;21, suppl:469–77.
7. Reeve J, Wootton R, Hesp R. A new method for calculating the accretion rate of bone calcium and some observations on the suitability of strontium-85 as a tracer for bone calcium. Calcif Tissue Res 1976; 20:121–35.
8. Meunier PJ, Bianchi GS, Edouard CM, Bernard JC, Courpron P, Vignon GE. Bony manifestations of thyrotoxicosis. Ortho Clin North Am 1972;3:745–74.
9. Schenk RK, Merz WA, Muller J. A quantitative histological study on bone resorption in human cancellous bone. Acta Anat (Basel) 1969; 74:44–53.
10. Matrajt H, Bordier P, Martin J, Hioco D. Technique pour l'inclusion des biopsies osseuse non décalcifiées. Journal de Microscopie 1967;6: 499–504.
11. Meunier PJ, Courpron P, Edouard C, Bernard J, Bringuier J, Vignon G. Physiological senile involution and pathological rarefaction of bone. Clin Endocrinol Metab 1973;2:239–56.
12. Meunier PJ, Edouard C, Courpron P, Toussaint F. Morphometric analysis of osteoid in iliac trabecular bone. Methodology: dynamic significance of the osteoid parameters. In: Norman AW, et al, eds. Vitamin D and problems related to uraemic bone disease. New York: Walter de Gruyter, 1975:149–55.
13. Parsons JA, Reit B, Robinson CJ. A bioassay for parathyroid hormone using chicks. Endocrinology 1972;92:454–62.
14. Cameron JR, Sorenson J. Measurement of bone mineral in vivo: an improved method. Science 1963;142:230–2.
15. West RR, Reed GW. The measurement of bone mineral in vivo by photon beam scanning. Br J Radiol 1970;43:886–93.
16. Bell GH, Dunbar O, Beck JS. Variations in strength of vertebrae with age and their relation to osteoporosis. Calcif Tissue Res 1967;1:75–86.
17. Boyce BF, Courpron P, Meunier PJ. Amount of bone in osteoporosis and physiological senile osteopenia: comparison of two histomorphometric parameters. Metabolic Bone Disease and Related Research 1978;1: 35–8.
18. Elsasser U, Hesp R, Klenerman L, Reeve J, Veall N, Wootton R. Deficit of trabecular and cortical bone in the radius in low-turnover osteoporosis. Clin Sci Mol Med 1979;57:22p.
19. Parsons V, Mitchell CJ, Reeve J, Hesp R. The use of sodium fluoride, vitamin D and calcium supplements in the treatment of patients with axial osteoporosis. Calcif Tissue Res 1977;22, suppl:236–40.
20. Meunier PJ, Bressot C, Vignon E, et al. Radiological and histological evolution of post-menopausal osteoporosis treated with sodium fluoride-vitamin D-calcium. Preliminary results. II CEMO symposium, Geneva. Medecine et Hygiene 1978:263–76.
21. Parsons JA, Zanelli JM, Gray D, et al. Double isotope estimates of intestinal calcium absorption in rats: enhancement by parathyroid hormone and 1,25 dihydroxycholecalciferol. Calcif Tissue Res 1977; 22, suppl:127–32.
22. 3 to hypocalcemia in human subjects. N Engl J Med 1978;299:437–41.
23. Frost HM. Tetracycline-based histological analysis of bone remodelling. Calcif Tissue Res 1970;3:211–37.